AddLife AB (publ) (0REZ.L)
- Previous Close
173.40 - Open
175.00 - Bid --
- Ask --
- Day's Range
174.60 - 183.00 - 52 Week Range
54.85 - 183.00 - Volume
27,440 - Avg. Volume
28,751 - Market Cap (intraday)
5.272B - Beta (5Y Monthly) 1.59
- PE Ratio (TTM)
0.31 - EPS (TTM)
5.87 - Earnings Date Jul 15, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis equipment. It offers products and solutions, including instruments and equipment, plastic consumables, cell biology, reagents, general lab, and other instruments used to diagnose diseases and conduct research. The Medtech segment provides medical device products for orthopedic, hospital consumables, critical care, endoscopy, wound care, healthcare it, ophthalmology, home adaptation, aid supply & equipment, welfare technology, and construction, as well as welfare technology and assistive technology for the elderly and people with disabilities. It operates in Sweden, the United Kingdom, Ireland, Spain, Denmark, Norway, Italy, Finland, Switzerland, Germany, and rest of world. AddLife AB (publ) was founded in 1906 and is based in Stockholm, Sweden.
www.add.life2,251
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Recent News: 0REZ.L
View MorePerformance Overview: 0REZ.L
Trailing total returns as of 5/1/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0REZ.L
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0REZ.L
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
2.97%
Return on Assets (ttm)
3.79%
Return on Equity (ttm)
6.05%
Revenue (ttm)
10.42B
Net Income Avi to Common (ttm)
309M
Diluted EPS (ttm)
5.87
Balance Sheet and Cash Flow
Total Cash (mrq)
368M
Total Debt/Equity (mrq)
93.42%
Levered Free Cash Flow (ttm)
1.04B